Humanity Unfolds

A personalized mRNA cancer-vaccine trial reports immune responses

May 10, 2023

A small phase I pancreatic-cancer study reports vaccine-induced T-cell responses in some patients after surgery and combination treatment.

An early clinical result for individualized cancer vaccines. It does not establish a cure or isolate the vaccine’s effect from the other treatments.

Explore on Humanity Unfolds

Sources